新型昆素类似物作为端粒G-四重复合联体,具有与增强免疫调节相关的抗瘤作用
Jia-Xin Wang1, Xiao-Dong Wang1, Ming-Hao Hu1
1Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China.
European journal of medicinal chemistry
|May 28, 2024
概括
一种新的昆素类似物R1有效准端粒G-四重复合体 (G4s),诱导瘤细胞死亡并增强免疫反应,以显著的抗瘤作用 in vivo.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 端粒DNA中的G四重复 (G4s) 是癌症治疗的关键标.
- 开发具有改善药物相似性和理解机制的新型G4配体至关重要.
研究的目的:
- 设计和合成针对端粒G4s的新型昆素类似物.
- 研究这些配体的抗瘤机制,重点关注R1.
主要方法:
- 合理设计和合成昆素类似物.
- 在体外细胞测试以评估G4稳定,DNA损伤,细胞循环停止,细胞亡和免疫细胞死亡 (ICD).
- 使用乳腺癌小鼠模型进行体内研究,以评估瘤负担和免疫调节效应.
主要成果:
- 昆素类似物R1显示出强大的细胞毒性作用和端粒G4稳定.
- R1诱导的R循环积累,DNA损伤反应,G2/M细胞周期停止,细胞亡和抗增殖.
- R1唤起了ICD,促进了树突细胞成熟,并通过免疫调节在体内减少了瘤负担.
结论:
- R1是一种有前途的端粒G4配体,具有显著的抗瘤活性.
- 用R1准端粒G4s诱导DNA损伤并增强抗瘤免疫力.
- R1提供了一种新的治疗策略,结合了直接细胞毒性和免疫调节.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:41Telomeres and Telomerase
23.3K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K